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The growing world of small heat shock proteins: from structure to functions
Abstract
Small heat shock proteins (sHSPs) are present in all kingdoms of life and play fundamental roles in cell
biology. sHSPs are key components of the cellular protein quality control system, acting as the first line of
defense against conditions that affect protein homeostasis and proteome stability, from bacteria to
plants to humans. sHSPs have the ability to bind to a large subset of substrates and to maintain them in a
state competent for refolding or clearance with the assistance of the HSP70 machinery. sHSPs
participate in a number of biological processes, from the cell cycle, to cell differentiation, from adaptation
to stressful conditions, to apoptosis, and, even, to the transformation of a cell into a malignant state. As a
consequence, sHSP malfunction has been implicated in abnormal placental development and preterm
deliveries, in the prognosis of several types of cancer, and in the development of neurological diseases.
Moreover, mutations in the genes encoding several mammalian sHSPs result in neurological, muscular, or
cardiac age-related diseases in humans. Loss of protein homeostasis due to protein aggregation is
typical of many age-related neurodegenerative and neuromuscular diseases. In light of the role of sHSPs
in the clearance of un/misfolded aggregation-prone substrates, pharmacological modulation of sHSP
expression or function and rescue of defective sHSPs represent possible routes to alleviate or cure
protein conformation diseases. Here, we report the latest news and views on sHSPs discussed by many
of the world's experts in the sHSP field during a dedicated workshop organized in Italy (Bertinoro, CEUB,
October 12-15, 2016).
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SUMMARY

Small Heat-Shock Proteins (sHSPs) are present in all kingdoms of life and play fundamental roles in
cell biology. sHPSs are key components of the cellular protein quality control system, acting as a first
line of defence against conditions that affect protein homeostasis and proteome stability, from bacteria
to plants and humans. Due to their ability to bind to a large subset of client proteins, maintaining them
in a state competent for refolding or clearance, with the assistance of the HSP70 machinery, sHSPs
participate to a number of biological processes, from cell cycle, to cell differentiation, from adaptation
to a stress, to apoptosis, and even in the transformation of a cell into a malignant state. As a
consequence, their malfunction has been implicated in various disorders e.g. abnormal placental
development and pre-term deliveries, the prognosis of several types of cancer, and the development of
neurological diseases. Moreover, mutations in the genes encoding for several mammalian sHSPs
result, in humans, in neurological, muscular and/or cardiac age-related diseases. In contrast,
considering that loss of protein homeostasis due to protein aggregation is typical of many age-related
neurodegenerative and neuromuscular diseases, and in light of the role of sHSPs in the clearance of
un/misfolded aggregation-prone clients, pharmacological modulation of sHSP expression or function,
and rescue of defective sHSPs represent possible routes to alleviate or cure protein conformational
diseases. Here, we report the latest news and views on sHSPs that were discussed by many of the
world’s experts in the sHSP field during a dedicated workshop organized in Italy (Bertinoro, Centro
Residenziale Universitario Bertinoro/CEUB, 12-15 October 2016).
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INTRODUCTION

Small Heat Shock Proteins (sHSPs) belong to the superfamily of HSPs and are expressed in all three
domains (viruses, archaea, bacteria and eukaryota) (Bult et al. 1996; Caspers et al. 1995; Eyles and
Gierasch 2010; Richter et al. 2010). sHSPs are characterized by a small molecular subunit mass,
ranging from ca. 15-40 kDa and by a highly conserved central domain, called the alpha-crystallin
domain (ACD) that represents their identification label. sHSPs exist as monomers and dimers, which
can also assemble into large multimeric complexes that vary in size and can contain up to 24-40
subunits (Candido 2002; Hilton et al. 2012; Kim et al. 1998; McDonald et al. 2012; van Montfort et
al. 2001). Association of monomers into large complexes, as well as dissociation of large oligomers
into dimers and monomers, is modulated by post-translational modification, including
phosphorylation, which in turn, regulates sHSP functions. sHSP functions are very diverse and
include molecular chaperone-like activities and modulation of cytoskeleton stability (Aquilina et al.
2004; Arrigo 2013; Bryantsev et al. 2002; den Engelsman et al. 2005; Ecroyd et al. 2007; Gaestel
2002; Lambert et al. 1999; Lavoie et al. 1995; Mehlen et al. 1997; Morrison et al. 2003; Morrow et al.
2015; Rogalla et al. 1999; Rouse et al. 1994; Theriault et al. 2004; Webster 2003).
As a consequence of their role as chaperones towards diverse clients, which influences client fate
(refolding or degradation) and due to their role as stabilizing agents of the cytoskeleton, sHSPs
indirectly participate in the regulation of complex processes such as the response and adaptation to
cell stress, including thermotolerance, cell differentiation, cell death and development (Arrigo 2000;
Arrigo and Ducasse 2002; Arrigo and Gibert 2014; Balogi et al. 2008; Benjamin et al. 1997; Bruey et
al. 2000; Haslbeck et al. 2016; Hong and Vierling 2000; Kamradt et al. 2002; Kamradt et al. 2005;
Lavoie et al. 1993; Lavoie et al. 1995; Litt et al. 1998; Nicholl and Quinlan 1994; Parcellier et al.
2006; Park et al.; Perng et al. 1999a; Perng et al. 1999b; Qian et al. 2009; Quinlan and Van Den Ijssel
1999; Takayama et al. 2003; Tanguay and Hightower 2015; Webster 2003). Thus, malfunction of
sHSPs can have adverse effects and these have been found to be causative of a wide range of
pathologies including cardiomyopathy, myofibrillar myopathy, motor neuron diseases and cataracts
(Evgrafov et al. 2004; Ghaoui et al. 2016; Irobi et al. 2004; Kolb et al. 2010; Perng et al. 1999b;
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Vicart et al. 1998). Understanding how sHSP function is regulated and elucidating how,
mechanistically, their malfunction is linked to disease will a have strong impact on cell biology and
disease and will help in the identification of potential drug targets.
In this review, we summarize the latest news and views concerning the structural and functional
properties of sHSP that were presented and discussed by 29 international experts during the Second
International Workshop of Cell Stress Society International (CSSI) on sHSPs, entitled “The small
HSP World” that was held in Centro Residenziale Universitario di Bertinoro, Italy (12-15 October
2016). This meeting followed up on the first Workshop held in Québec, Canada (Tanguay &
Hightower, 2014).

New insights into the structure of sHSPs and their interaction with clients
As mentioned above, sHSPs have a dynamic structure that spans from monomers/dimers to large
oligomers (Hilton et al. 2012; van Montfort et al. 2001). Oligomerization and dynamics affect their
binding affinity to specific subsets of clients and, therefore, sHSP functions (Delbecq and Klevit
2013; Delbecq et al. 2015; Ecroyd et al. 2007; Giese et al. 2005; Giese and Vierling 2002; McDonald
et al. 2012; McHaourab et al. 2002; Stromer et al. 2004). Thus, understanding how sHSPs
oligomerize, identifying their preferred oligomerization state (in resting conditions or upon stress),
what regulates their transition from small oligomers into large oligomers and how this influences their
binding to clients is crucial to pinpoint sHSP function (Mainz et al. 2015). This information will also
help in designing strategies and drugs that may stabilize one conformation, thereby modulating
specific sHSP functions, with potential application in cell stress response, apoptosis and disease.

sHSPs are composed of a N-terminal domain (NTD), a C-terminal domain (CTD) and a middle highly
conserved region, called the alpha-crystallin domain (ACD) (van Montfort et al. 2001). In contrast to
the alpha-crystallin domain, the C-terminal and the N-terminal domains of sHSPs are poorly
conserved amongst the various members and across the various species. However, structural and
functional studies have demonstrated that all these three domains play important role in sHSP
oligomerization and function (Mainz et al. 2015; McDonald et al. 2012; van Montfort et al. 2001).
6

Cecilia Emanuelsson (Sweden) presented data on Hsp21, the chloroplast-localized sHSP, and
suggested a role for the N-terminal and C-terminal tails in the stabilization of oligomers and in the
accessibility for interaction of the oligomer itself with clients (Ahrman et al. 2007a; Ahrman et al.
2007b; Lambert et al. 2011). In particular, a structural model of Hsp21, obtained after homology
modelling and fitting to cryo-EM, shows two hexameric discs rotated by 30 degrees and separated
further by 35 Å compared to the crystal structure of the cytosolic homologue Hsp16.9. This model
suggests that the Hsp21 dodecamer is stabilized by the C-terminal tails, which are shorter than in
Hsp16.9 and human HSPB5, and with the IXI-motif extended to IXVXI. The flexible N-terminal
arms, unusually long and with functionally important and conserved methionines, appear on the
outside of the dodecamer, as supported by limited proteolysis, difference density maps and NMR.
Thus, even without subunit dissociation, they may be accessible for transient interaction with client
proteins.
The theme of combining structural and biophysical methods to elucidate structural details on sHSPs
was continued by Justin Benesch (UK). With native mass spectrometry experiments acting as a
thread, he presented new data from a collaboration with Elizabeth Vierling that explained how
different evolutionary classes of sHSPs from plants that are found in the same cellular compartment
manage to avoid co-assembly (Basha et al. 2010; Painter et al. 2008; Sobott et al. 2002). This
presentation highlighted how rich and complex the self- and co-assembly processes of sHSPs are, and
the bewildering heterogeneity of the complexes resulting from chaperone activity (Stengel et al. 2012;
Stengel et al. 2010).
Regulation of sHSP homo- and hetero-oligomerization is indeed one way of regulating the binding
affinity of sHSPs for a given client (Delbecq et al. 2015; Rajagopal et al. 2015). In line with this
concept, Rachel Klevit (USA) presented studies aimed at defining how HSPB5 interacts with a
destabilized client protein. Klevit’s group compared three mutant forms of HSPB5 that each mimic a
different mode of activation to “unactivated” (wild-type) HSPB5. Interactions between destabilized αlactalbumin and HSPB5 were analyzed in four different biochemical/biophysical assays that allow
detection of species at different stages along the aggregation pathway. Based on the presented results,
Dr. Klevit suggested a model in which unactivated HSPB5 interacts transiently with very early
7

species, while activated forms of HSPB5 can also interact with client species that are further along the
aggregation pathway, providing them with additional capability to delay the onset of amorphous
aggregates (Rajagopal et al. 2015).
A comparative study performed by Robert M Tanguay (Canada) further highlighted the impact of the
oligomerization state on sHsp function and chaperone-like activity. Following up on their previous in
silico report of small Hsps in viruses of the Synechococcus cyanobacteria, Robert Tanguay described
the properties of the viral and bacterial sHsps protein using size-exclusion chromatography (SEC),
native gels, dynamic light scattering (DLS) and chaperone assays (Bourrelle-Langlois et al. 2016;
Maaroufi and Tanguay 2013). The cyanophage sHsp forms large oligomers and shows a polydisperse
profile (in collaboration with Dr. Stephanie Finet); it exerts chaperone-like activity through the
formation of stable and soluble hetero-oligomeric complexes (sHSP:substrate/client). In contrast, the
host cyanobacteria sHsp formed a small dimer and tetramer and showed no chaperone-like activity in
the assays tested (malate dehydrogenase/MDH, citrate synthase/CS, luciferase/Luc) (BourrelleLanglois et al. 2016).
The regulation of the oligomerization state of sHSPs can be influenced by several factors, including
post-translational modifications, but also oxidation and crowding agents (Haslbeck et al. 2016).
Indeed, on behalf of Sevil Weinkauf´s lab, Martin Haslbeck (Germany) presented the oligomer
structures of human αA-crystallin (HSPB4) obtained by cryo-electron microscopy (Peschek et al.
2009). The oligomers form barrel-like structures consisting of tetrameric units. As seen in the pseudoatomic model, the tetramers assemble mainly via N-terminal interactions while the C-terminal tails
exist in 3D non-domain swapped and domain swapped configurations. The oxidation of HSPB4, i.e.
the formation of an intra-molecular disulfide bond as observed in vivo, seems to be coupled with
conformational changes involving C-terminal domain swapping. They concluded that the oxidized
protein shows enhanced subunit dynamics and increased ability in suppressing the aggregation of
model substrates.
Next, John Carver (Australia) presented recent work relating to the principal eye lens proteins,
HSPB4 and αB-crystallin (HSPB5) (Cox et al. 2014; Cox et al. 2016; Hochberg et al. 2014). Firstly,
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he described structural and functional studies of Q147E HSPB4, a major site of deamidation in agerelated cataract which leads to a slight reduction in chaperone ability, enhanced temperature stability
and a small increase in oligomeric mass. Similar observations for other deamidated crystallins may
reflect a general evolutionary adjustment to crystallins with age to counter the extensive posttranslational modifications that potentially affect lens transparency (Ray et al., submitted for
publication). Secondly, he presented small-angle neutron scattering analysis of deuterated HSPB5 in
the presence of crowding agents at high concentration comparable to that of crystallins in the centre of
the lens. It was concluded that these conditions lead to destabilisation, unfolding and aggregation of
HSPB5. This study further highlights the dynamic nature of sHSPs and how external factors are
important to regulate their structure (and in turn, function), with consequences on cell viability and
fitness (Treweek et al. 2015).
The importance of structural studies for the understanding of sHSP binding to clients and, as a
consequence, function, has been further highlighted by Sergei Strelkov (Belgium), who reported on
structural studies of human HSPB6, which is predominantly dimeric in isolation (Heirbaut et al. 2014;
Weeks et al. 2014). Phosphorylation of HSPB6 within its intrinsically disordered N-terminal domain
(NTD) results in a complex formation with the universal signalling hub 14-3-3 protein (Sluchanko et
al. 2011), a process that can trigger smooth muscle relaxation. In collaboration with Nikolai Gusev
and Nikolai Sluchanko, the Strelkov lab has succeeded in determining the crystal structure of the
entire 14-3-3/pHSPB6 heterotetrameric complex (Sluchanko et al. 2017). As a result, the first-ever
atomic resolution snapshot of a mammalian small HSP in a functional state has been obtained.
Interestingly, formation of the complex results in partial ordering of the NTD. In addition, the
formation of the HSPB1/HSPB6 hetero-oligomer formation, which turns out to be driven by specific
sequences within the NTD of HSPB6, was discussed (Heirbaut et al. 2014; Sluchanko et al. 2011).
Finally, André-Patrick Arrigo (France) further stressed the importance of changes in the
phosphorylation, oligomerization state and native molecular size in the regulation of sHSP interaction
with clients (Arrigo 2013). He summarized the modifications that occur in HSPB1
phosphorylation/oligomerization and native state in cells undergoing changes in their physiology or
being exposed to environmental stressors. It was concluded that the changes in HSPB1 organization
9

are highly condition-specific and phosphorylation and oligomerization, which dynamically react to
different cell conditions, were suggested as key factors involved in the generation of HSPB1
platforms that can recognize specific clients, such as F-actin or damaged proteins. In particular, in
response to heat shock, damaged polypeptides are stored in HSPB1 large structures that have a
phosphorylation specific signature: P-Ser15, P-Ser82. Another important point that was discussed is
that these conformational changes are very transient, and, thereby, they likely trigger signals, through
transient and specific interaction with selected clients; such changes in the HSPB1-client partnerships
would allow cells to react and adapt (Arrigo 2000; Arrigo 2007; Arrigo and Gibert 2012).

Combined, these works further illustrate the complexity of sHSP structure/function, with some sHSPs
stabilizing oligomeric structures to favour binding to specific clients and other sHSPs avoiding coassembly to bind to other subsets of clients (or other conformations/aggregation states of the same
client); the level of complexity of the relation between sHSP configuration and its binding to a given
substrate is further increased when considering that these structural and functional aspects can all be
influenced by post-translational modifications or oxidation of the sHSP itself and by crowding
conditions of the neighbouring environment. As pointed out by André-Patrick Arrigo, cell-cell contact
also may play a role in the regulation of sHSP structure, further increasing the level of complexity.

From the technical point of view, the main methods employed to study sHSP structure include e.g.
mass spectrometry, electron microscopy, NMR and cryo-EM (Baldwin et al. 2012; Benesch et al.
2006; Kondrat et al. 2015; Lambert et al. 2011; Mainz et al. 2015; Shi et al. 2012). Kathryn
McMenimen (USA) presented data using HspB1 N-terminal region peptides conjugated to gold
nanoparticles and showed that these peptides exhibited concentration-dependent chaperone activity
toward citrate synthase (CS) and malate dehydrogenase (MDH). These studies seek to understand the
role of oligomerization in chaperone activity and how substrate/client specificity is determined for
sHsps, with the use of gold nanoparticles. In addition, the use of different scattering techniques is also
beneficial to characterize the structural and functional properties of various sHSPs, as discussed by
Stephanie Finet (France). She presented data concerning nuclear Hsp27 from Drosophila
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melanogaster, obtained in collaboration with Robert Tanguay’s group (Michaud et al. 2008;
Moutaoufik et al. 2016). The use of these techniques demonstrated that the major population of
DmHsp27 obtained after a two-step chromatography purification was monodisperse and compatible
with globular oligomers constituted by 18-20 SU, similar to the smallest population previously
produced with a His-tag construct. The effects of mutations of the arginine residues in the ACD of the
nuclear Hsp27 of Drosophila were also evaluated by Robert M Tanguay (Canada) in collaboration
with Stephanie Finet. While 2 forms of the WT were seen in native gels and in SEC, mutants of
R122G, R131G and R135G showed only one peak. The mutants also had the same chaperone-like
activity. Finally, the use of the tags and their influence of sHSP structure and oligomerization were
also discussed and the general consensus is that comparison between untagged and tagged sHSP
forms must be performed, especially in test-tube assays, to avoid possible misinterpretations due to
the tag.

From the methodological point of view, a new method that may become useful to study the dynamic
oligomerization of sHSPs has been proposed by Wilbert Boelens (The Netherlands). In particular, he
presented a method by which the interaction of monomers and dimers with HSPB5 complexes can be
analyzed using surface plasmon resonance (Bruinsma et al. 2011). HSPB5 complexes contain
between 20 and 40 subunits, which are in equilibrium with monomers and dimers. This dynamic
behavior is highly regulated and is crucial for the chaperoning activity. Up to now most studies have
focused on the dynamic behavior of the multimeric complexes and not so much on the subunits. By
analyzing how monomers and dimers interact with HSPB5 complexes more insight will be obtained
into the dynamic behavior of HSPB5. The use of optical tweezers to study biophysical properties of
sHSPs and their ability to partition may also represent a promising new approach to understand sHSP
structure and function, as suggested by Simon Alberti (Germany) (Sudnitsyna et al. 2011).

Lessons from in vitro studies: chaperone-like activity, cooperation with the HSP70 machine and
fate of the sHSP-bound client
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In contrast to HSP70, HSP90 and HSP100, sHSPs do not possess ATPase activity. Thus, while
chaperones with ATPase activity are classified as chaperone “foldases”, sHSPs are classified as
chaperone “holdases”, since they can recognize and bind to unfolded and/or misfolded
substrates/clients, and “hold” them avoiding their irreversible aggregation, although this is not their
only mechanism of chaperone action (Ecroyd 2015). This holdase-action in turn favours the
processing of the sHSP-bound client by the downstream ATP-dependent chaperones such as e.g.
HSP70s (De Los Rios and Goloubinoff 2016; Vos et al. 2008). Thus, sHSPs, which bind to a large
variety of client proteins, and in doing so act as the first line of defence for the maintenance of cellular
proteostasis (Haslbeck and Vierling 2015). In this context, Pierre Goloubinoff (Switzerland) presented
results from quantitative proteomic studies from an E. coli knockout mutant of DnaK/J (de Marco et
al. 2005). He showed that this mutant constitutively over-expressed massive amounts of small HSPs
IbpA/B, Trigger factor and ATP-dependent chaperones and proteases. The strong upregulation of
sHSPs in this mutant further supports their requirement as a first line of defence under conditions that
favour the accumulation of proteins in the non-native state. This can occur also in resting cells, where
labile proteins that spontaneously tend to misfold would be constantly restored and maintained in a
metastable native state by an active network of ATP-fuelled unfoldases, assisted by small HSPs (De
Los Rios and Goloubinoff 2016; Veinger et al. 1998).
Intriguingly, Bernd Bukau (Germany) presented a comparative biochemical analysis of the two sHsps
acting in the cytosol of S. cerevisiae, Hsp26 and Hsp42. The results reveal that heat denatured model
substrates are retained in near native state and kept physically separated when complexed with either
sHsp, while being unfolded when aggregated without sHsps. However, the fate of the sHSP bound
substrate largely depends on its cooperation with the Hsp70/Hsp100 machineries, and on sHSP ability
to act in conjunction with this machinery in disaggregation (Ungelenk et al. 2016). In fact, it was
discussed that Hsp26, which lacks disaggregase function, is superior in facilitating Hsp70/Hsp100dependent post-stress refolding. Instead, Hsp42 forms with misfolded proteins light scattering
aggregates in vitro and microscopically visible large assemblies in the yeast cytosol; formation of
these aggregates specifically ensures cellular fitness during repeated heat stress (Ungelenk et al.
2016). The presented findings indicate that the sHSPs of a cell functionally diversify in stress defence,
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but share the working principle to promote sequestration of misfolding proteins for storage in nativelike conformation. They also further highlight the requirement to cooperate with the Hsp70/Hsp100
machineries to ensure client refolding.
Krzysztof Liberek (Poland) presented recent advance in the understanding of how bacterial sHSPs
cooperate with the HSP70 machinery (Strozecka et al. 2012). Under heat stress conditions sHSPs
form assemblies with misfolded proteins, preventing them from further aggregation and keeping them
in a refoldable state that facilitates subsequent solubilisation and refolding by ATP-dependent Hsp70
and Hsp100 chaperones. The refolding of substrates from sHsp-substrate assemblies requires the
disruption of sHSP association with trapped misfolded proteins. This process depends on Hsp70.
Hsp70 acts in a passive manner by outcompeting sHSP molecules that dynamically interact with the
surface of sHSP-substrate assemblies. Hsp70 binding to assemblies preserves their architecture
following dissociation of sHSPs and allows for superior substrate solubilisation and refolding upon
Hsp100 recruitment (Żwirowski S. et al. 2017).

Functional studies of sHSPs: from in vitro assays to combined in vitro/cell assays to understand
sHSP cellular activities
In vitro assays with pure recombinant sHSPs are fundamental to understand the structural properties
of sHSPs, their oligomerizaton state and how post-translational modifications or disease-linked
mutations affect them. Test-tube studies are also required to test and compare the chaperone-like
activity of the various sHSPs towards a specific subset of client proteins, allowing how structural
differences in sHSPs result in different chaperone efficacy to be highlighted. In particular, Johannes
Buchner (Germany) reported the first comparative analysis of 8 human sHSPs with a view to
determine their relative chaperone properties (Mymrikov et al. 2016). Amorphous aggregation assays
using several model substrate proteins under standard conditions revealed differences between assays
and sHSPs. Generally, the large oligomeric sHSPs (HSPB1, HSPB4 and HSPB5) and also HSPB3
proved to be promiscuous chaperones suppressing the aggregation of various substrate proteins. Then,
he combined pure recombinant proteins to cell lysates to test and compare the activity of the pure
sHSPs to prevent heat-induced protein aggregation in the context of a whole cell lysate. A different
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picture emerged in this cell lysate aggregation assays. Here, all sHSPs tested, except HSPB7, were
active. These different properties between sHSPs were dependent on, of course, the structural
organization and oligomerization of the various sHSPs, as well as their ability to bind with different
affinities to a large number of clients, properties that are, to some extent, linked. In line, substrate
spectra of the sHSPs determined after immunoprecipitation by mass spectrometry identified a large
number of interactors, which revealed general properties and functional classes amongst the 8 human
sHSPs compared (Mymrikov et al. 2016).
Similarly, Nikolai Gusev (Russia) compared the interaction of mammalian HSPBs with the light
component of neurofilaments (NFL), further highlighting similarities but also differences. HSPB1,
HSPB5, HSPB6 and HSPB8 were equally effective in preventing NFL bundling and decreased the
quantity of filaments pelleted after low speed centrifugation (Nefedova et al. 2016). HSPB1 and
HSPB5 affected kinetics of NFL polymerization and decreased NFL pelleting after high speed
centrifugation, probably by affecting hydrodynamic properties of filaments. HSPB8 and especially
HSPB6 weakly interacted with NFL but were less effective in modulation of NFL polymerization.
Interestingly, sHSPs did not interact with NFL tetramers; however they influenced transition from
tetramers to mature filaments, hydrodynamic properties of filaments and their bundling (Nefedova et
al. 2016).

Once a client is identified by co-immunoprecipitation and interaction studies, more thorough analysis
can be done to understand in detail the biophysical nature of such interaction. In fact, Justin Benesch
(UK) showed how to successfully use mass spectrometry and other biophysical methods to elucidate
the structure, and quantify the underpinning thermodynamics and kinetics, of sHSP interactions with
target proteins. He first revealed a molecular mechanism by which HSPB5 interacts with titin, the
giant muscle protein, and modulates the stiffness of heart tissue (Zhu et al. 2009).

Thus, a combination of in vitro and combined in vitro/cell assays have proven to be extremely useful
approaches to provide detailed insights in sHSP structure and interaction with clients, with the
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identification of the functional significance of such interaction (HSP70-assisted refolding, holding or
assembly formation).
The information obtained from these approaches will help in the interpretation and understanding of
functional studies in more complex systems such as endogenous or exogenous expression of a given
sHSP in prokaryotic or eukaryotic cells, where post-translational modification of sHSPs or mutation
play a role in their regulation or even in whole organisms.

Functional studies of sHSPs in cells and organisms: dissecting their role in keeping the balance
and beyond
Although some sHSPs are constitutively expressed, their levels can be increased upon diverse stress
conditions, supporting their implication in the cell and organismal stress response. Elizabeth Vierling
(USA) presented data concerning higher plants, which express 11 or more distinct gene families of
sHSPs, including multiple cytosolic proteins and proteins targeted to every cellular organelle. Vierling
used RNAi in transgenic Arabidopsis plants to suppress expression of either cytosolic Class I or II
sHSPs, which are the most abundant sHSPs produced during heat stress (McLoughlin et al. 2016).
The transgenic plants are sensitive to severe heat stress, consistent with a non-redundant function of
these sHSPs. CI and CII proteins also showed distinct biochemical behavior in vitro and in vivo.
Thirty six proteins that were specifically associated with affinity-tagged CI sHSPs during heat stress
in vivo were identified by mass spectrometry. Of these, twelve are involved in translation and have
previously been identified as components of heat stress granules in yeast. These data support the
hypothesis that CI sHSPs are involved in recovery of translation after heat stress (McLoughlin et al.
2016).
A similar question (the role of sHSPs in stress response) was addressed from a different perspective
and using a different model by Melinda Toth (Hungary), who, in collaboration with Miklós Sántha’s
and László Vígh’s groups studied the role of HSPB1 in the regulation of neuroinflammation (Toth et
al. 2010; Toth et al. 2014). As a model system they used a HSPB1 overexpressing transgenic mouse
strain. In their latest studies, neuronal damage was induced by a single day of ethanol treatment in 7
day-old mice. Expression levels of inflammatory cytokines and markers of astrocyte and microglia
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activation were doubled in the wild-type animals 24 hours after the ethanol treatment, while some of
them showed a much higher increase in the ethanol treated transgenic mice, suggesting that HSPB1
can promote cytokine response in the brain in vivo, under acute brain injury. This implies that sHSPs
might play a specific function at the neuronal level, an area that has been addressed by Nikola
Golenhofen and Britta Bartelt-Kirbach (Germany), who showed that HSPB5 possesses powerful
neuroprotective capacity in the brain (Bartelt-Kirbach et al. 2016; Golenhofen and Bartelt-Kirbach
2016; Schmidt et al. 2016). They overexpressed HSPB5 in hippocampal neurons to get insights into
its function particularly in neurons. Whereas axon length and synapse density were not affected,
HSPB5 increased significantly the complexity of the dendritic tree. This stimulating effect of HSPB5
on dendritic branching might become especially relevant during neurodegenerative diseases in
dysfunctional neurons with reduced dendritic complexity. Based on their results, Golenhofen’s group
hypothesized that endogenous upregulation of HSPB5 may serve to maintain dendritic structure and
neuronal connectivity (Bartelt-Kirbach et al. 2016).
Further evidence for a protective role of HSPBs in neuronal cells comes from the work presented by
Angelo Poletti (Italy), who found a specific upregulation of HSPB8 in motor neurons that survive at
end stage of disease in the spinal cord of mice carrying a mutation in the SOD1 gene linked with
amyotrophic lateral sclerosis (ALS) (Crippa et al. 2010). Mechanistic studies in cell models
expressing a variety of disease associated mutant proteins (mutant SOD1, TDP-43, ARpolyQ) (Crippa
et al. 2010; Rusmini et al. 2013) or dipeptides generated by abnormal translation of the C9ORF72
gene product showed that HSPB8 overexpression counteracts their accumulation. This HSPB8
activity is likely mediated by the facilitation of the autophagic system and by enhancing the routing of
these various misfolded proteins to the autophagosomes (Cristofani et al, Autophagy 2017 in press).
Heath Ecroyd (Australia) extended this protective effect of HSPBs in yet another neurodegenerative
disease model, Parkinson’s disease, which is characterized by the accumulation of alpha-synuclein
into amyloid fibrils. Previous work already demonstrated that the protein deposits associated with
diseases such as Parkinson’s disease and other motor neuron diseases contain high levels of e.g.
HSPB1 and HSPB5 (Cox et al. 2014; Ecroyd and Carver 2009). Heath Ecroyd presented data
demonstrating that HSPB1 and HSPB5 bind stably to amyloid fibrils formed by alpha-synuclein and,
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in doing so, prevent the cytotoxicity associated with the fibril. Moreover, HSPB1 and HSPB5 can
prevent the aggregation of alpha-synuclein in cells (Cox et al. 2014; Cox et al. 2016). Interestingly,
Ecroyd proposed that these sHSPs should not be considered generic inhibitors of protein aggregation
in cells, but rather act in cells on specific intermediate states or substrates; in support of this he
reported that HSPB1 and HSPB5 had no effect on the intracellular aggregation of the substrate firefly
luciferase.
Finally, Hassane Mchaourab (USA) presented data concerning the use of zebrafish as model to study
the properties and functions of sHSPs. In particular, he reported on the utility to use zebrafish as
model to study cataract and identify key players of the proteostasis network that are required to
maintaing lens transparency (Wu et al. 2016).

sHSP in cardiac and muscular diseases
The family of mammalian sHSPs (HSPBs) includes 10 members (HSPB1-HSPB10). While some
members are widely expressed, such as e.g. HSPB1, HSPB5 and HSPB8 other members show a very
restricted expression pattern; for example, HSPB4 is mainly expressed in the lens, although it was
recently also found in pancreatic cells, where it negatively regulates tumorigenesis (Kappe et al. 2003;
Liu et al. 2016). HSPB2 and HSPB3 are specifically expressed in differentiating and mature cardiac
and muscle cells, while HSPB9 and HSPB10 are testis specific (Fontaine et al. 2003; Kappe et al.
2003; Sugiyama et al. 2000; Suzuki et al. 1998; Verschuure et al. 2003). Cardiac and skeletal muscle
cells express the largest variety of sHSPs: HSPB1, HSPB2, HSPB3, HSPB6, HSPB7 and HSPB8.
Evidence exists supporting their important role for the viability and function of myocardium, skeletal
muscles and neuromuscular systems. Moreover, mutations in HSPB1, HSPB3, HSPB5 and HSPB8
have been directly associated with myofibrillar myopathy or motor neuron disease, providing further
evidence for the importance of these sHSPs in muscle and motor neuron maintenance (Boncoraglio et
al. 2012). sHSPs mutations could lead to disease both via a loss of function or gain of toxic function
mechanisms, or both. During this meeting, Harm H Kampinga (The Netherlands) showed data about
mutations in HSPB5 related to dominantly inherited (cardio)myopathies (Bova et al. 1999; Hishiya et
al. 2010; Perng et al. 1999b; Rajasekaran et al. 2007; Simon et al. 2007; Treweek et al. 2005; Vicart et
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al. 1998). Expression of these mutants in cardiomyocytes leads to the accumulation of HSPB5
aggregates that are positive for ubiquitin and are associated with contractile dysfunction. Aggregation
reverted upon introduction of second mutations in the IXI motif or hydrophobic pocket in the alphacrystallin domain. This suggests that the mutants act via a dominant negative effect on heterooligomeric complexe dynamics, which can be alleviated by weakening their inter-dimer interactions
(Vonk et al., in preparation). This is in line with published findings that aggregation of mutant HSPB5
forms can be alleviated by increasing the levels of those other HSPB members that hetero-oligomerize
with HSPB5, including wildtype HSPB5 itself (Hussein et al. 2015). Ivor J. Benjamin (United States)
discussed the disease modelling of early childhood myofibrillar myopathy caused by a homozygous
recessive mutation in HSPB5, 343delT (Mitzelfelt et al. 2016). Both standard cell culture systems and
induced pluripotent stem cells (iPSCs), derived from the 343delT patient (343delT/343delT), were
used to characterize HSPB5 343delT protein dynamics in skeletal myotubes (iSKMs) and
cardiomyocytes (iCMs). The truncated protein found in the patient was extremely insoluble under
basal conditions and was only observed after HSPB5 343delT overexpression with induction of a
cellular stress response. HSPB5 343delT is a classic loss of function mutation; the additional findings
that the solubilization of 343delT by WT could explain the absence of symptoms in carrier individuals
(Mitzelfelt et al. 2016). Serena Carra (Italy) reported the identification of two novel mutations in the
HSPB3 gene in patients affected by myopathy (Carra unpublished). The two mutations of HSPB3
identified by Carra’s group lead to protein aggregation or truncation and destabilization, respectively.
Interestingly, both mutations, directly or indirectly, abrogate HSPB2-HSPB3 complex formation,
leading to an exceeding free pool of HSPB2 that tends to mislocalize inside the cells (Carra
unpublished). Dr. Carra discussed the possibility that deregulated HSPB2-HSPB3 interaction would
lead to deregulation of HSPB2, with potential consequences on myoblast function and viability.
Combined these studies highlight that imbalances in the expression levels and solubility of specific
sHSPs, due to aggregation propensity and deregulated association with other sHSPs or other clients,
could be the basis of complex diseases such as myopathies and neuromuscular diseases.
Conversely, upregulation of specific sHSPs may protect against cardiac and muscular cell dysfunction
and atrophy. Bianca Brundel (The Netherlands) presented work demonstrating the implication of
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specific HSPBs in atrial fibrillation (AF) (Ke et al. 2011). AF is the most common sustained clinical
tachyarrhythmia. AF is a progressive condition as demonstrated by the finding that maintenance of
normal rhythm and contractile function becomes more difficult the longer AF exists (de Groot et al.
2010; Hoogstra-Berends et al. 2012). Recent investigations reveal that HSPB1, HSPB6, HSPB7 and
HSPB8 attenuate the promotion of AF in both cellular and Drosophila melanogaster experimental
models (Hoogstra-Berends et al. 2012; Ke et al. 2011). Furthermore, studies in humans suggest a
protective role for sHSPs against progression from paroxysmal AF to chronic, persistent AF (Brundel
et al. 2006). Therefore, manipulation of the HSP system may offer novel therapeutic approaches for
the prevention of atrial remodelling.

In addition, the cross-talk between specific sHSPs and the intermediate filaments of the cytoskeleton
and its implication in disease was discussed. Roy Quinlan (UK) highlighted the fact that mutations in
sHSPs cause cataract, myopathies and neuropathies and these are phenocopied by mutations in
intermediate filament proteins (Toivola et al. 2010). The histopathological aggregates that typify such
diseases always contain both intermediate filaments and sHSPs. Nevertheless the bigger picture is that
HSPs, like intermediate filaments, are stress responsive and together the chaperones and cytoskeleton
integrate every aspect of cell biology. Mutations subvert this role and diseases ensue (Perng et al.
1999a; Perng et al. 2016; Perng et al. 1999b; Perng et al. 2004). Thus, Roy Quinlan proposed that
sHSPs, like other chaperones, are evolutionary capacitors given their role in cell proliferation, cell
death, shape and function, redox potential and ATP levels. However, they should not only be looked
at as factors that prevent and control protein misfolding and/or their subsequent aggregation; sHSPs
cooperate with the intermediate filament cytoskeleton to act as a transcellular network that not only
partitions efficiently the intracellular space of individual cells, but also integrates the individual cell
into the context of the tissue, with far more complex implication in (cardiac and muscle) tissue
maintenance/function.

Conclusions and future perspectives
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The purpose of the Bertinoro workshop was to bring together investigators representing core
laboratories in the sHSP field in order to identify and discuss current and future trends in sHSP
research. The workshop was successful in that new trends were featured including characterizations of
a rapidly expanding repertoire of binding partners, association with a variety of diseases, elaboration
of the roles of sHSPs as stability sensors, development of drugs to induce sHSPs, creating protected
pre-surgical states and post-surgical therapies in humans, expanding the concept of sHSPs as
polydisperse dynamic oligomers, to name several but not all.

Another example of the growing interest in this field is the recent establishment of a database
(sHSPdb) for analyses of sHSPs by Jaspard and Hunault (Jaspard and Hunault 2016). To
accommodate the increased research efforts on sHSPs, the third in this meeting series will be held in
Québec, Canada, in 2018. It will be expanded from a workshop into a CSSI symposium of about 100
participants, principally organized by Robert M. Tanguay.
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